Product Categories
| Country: | China |
|---|---|
| Tel: | 00-13720134139 +86 -0-15871494362 |
| Mobile: | 13720134139 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| BIIB021 | C14H15ClN6O | 848695-25-0 | Details |
| LY2090314 | C28H25FN6O3 | 603288-22-8 | Details |
| Roscovitine | C19H26N6O | 186692-46-6 | Details |
| Borussertib | C36H32N6O3 | 1800070-77-2 | Details |
| BI-882370 | C28H33F2N7O2S | 1392429-79-6 | Details |
| ABT 737 | C42H45ClN6O5S2 | 852808-04-9 | Details |
| Umbralisib | C31H24F3N5O3 | 1532533-67-7 | Details |
| AT406 | C33H44N4O5 | 1290536-79-6 | Details |
| SM-164 | C62H84N14O6 | 957135-43-2 | Details |
| Ibet762 | C22H22ClN5O2 | 1260907-17-2 | Details |
| GSK126 | C31H38N6O2 | 1346574-57-9 | Details |
| CYT997 | C24H30N6O2 | 917111-44-5 | Details |
| (+)-Blebbistatin | C18H16N2O2 | 1177356-70-5 | Details |
| (-)-Blebbistatin | C18H16N2O2 | 856925-71-8 | Details |
| (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate | C23H25ClN4O2S | 1268524-70-4 | Details |
| Veliparib dihydrochloride | C13H16N4O | 912445-05-7 | Details |
| CHIKV-IN-2 | C23H26N2O2 | 2361289-44-1 | Details |
| SB-435495 | C38H40F4N6O2S | 304694-39-1 | Details |
| Rilapladib | C40H38F5N3O3S | 412950-08-4 | Details |
| LeterMovir | C29H28F4N4O4 | 917389-32-3 | Details |
| MC-Gly-Gly-Phe-OH | C23H28N4O7 | 1599440-15-9 | Details |
| Cbz-Gly-Gly-Phe | C21H23N3O6 | 13171-93-2 | Details |
| Boc-Val-Cit-PAB-PNP | C30H40N6O10 | 870487-10-8 | Details |
| Fmoc-Ala-Ala-Asn(Trt)-PAB | C51H49N5O7 | 1834515-99-9 | Details |
| MC-Ala-Ala-Asn(Trt)-PAB | C46H50N6O8 | 1638970-43-0 | Details |
| MC-Ala-Ala-Asn-PAB | C27H36N6O8 | 1638970-44-1 | Details |
| Ala-Ala-Asn-PAB | C17H25N5O5 | 2149584-00-7 | Details |
| Boc-Gly-Gly-Phe-Gly | C20H28N4O7 | 187794-49-6 | Details |
| MC-Val-Cit-PAB-Cl | C28H39ClN6O6 | 1639351-92-0 | Details |
| Fmoc-Ala-Ala-Asn(Trt)-OH | C44H42N4O7 | 1951424-92-2 | Details |
| Boc-Val-Cit-PAB-OH | C23H37N5O6 | 870487-09-5 | Details |
| Fmoc-Val-Cit-PAB-PNP | C40H42N6O10 | 863971-53-3 | Details |
| Val-Cit-PAB-OH | C18H29N5O4 | 159857-79-1 | Details |
| MC-Val-Cit-PAB-OH | C28H40N6O7 | 159857-80-4 | Details |
| MC-Val-Cit-PAB-PNP | C35H43N7O11 | 159857-81-5 | Details |
| Fmoc-Val-OSU | C24H24N2O6 | 688585-20-8 | Details |
| Fmoc-Val-Cit-OH | C26H32N4O6 | 159858-21-6 | Details |
| FMoc-Val-Cit-PAB | C33H39N5O6 | 159858-22-7 | Details |
| Nalfurafine Impurity 16 | C28H34N2O3 | 152657-00-6 | Details |
| GSK-LSD1 2HCl | C14H20N2 | 1431368-48-7 | Details |
| Paliperidone | C23H27FN4O3 | 144598-75-4 | Details |
| DODECYL PHOSPHOCHOLINE | C17H38NO4P | 29557-51-5 | Details |
| mln9708 | C20H23BCl2N2O9 | 1201902-80-8 | Details |
| GSK2879552 | C23H28N2O2 | 1401966-69-5 | Details |
| UMI-77 | C18H14BrNO5S2 | 518303-20-3 | Details |
| 2,6-Piperidinedione, 3-(5-bromo-4-fluoro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)- | C13H10BrFN2O3 | 2408391-89-7 | Details |
| 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4,5-difluoro- | C13H8F2N2O4 | 2222115-19-5 | Details |
| 2,6-Piperidinedione, 3-[1,3-dihydro-6-(hydroxymethyl)-1-oxo-2H-isoindol-2-yl]- | C14H14N2O4 | 2803882-16-6 | Details |
| 2,6-Piperidinedione, 3-[6-(aminomethyl)-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-, hydrochloride (1:1) | C14H16ClN3O3 | 2248702-12-5 | Details |
| 1H-Pyrrolo[3,4-g]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5,6,7,8-tetrahydro-, hydrochloride (1:1) | C16H16ClN3O4 | 2616553-33-2 | Details |
| INDEX NAME NOT YET ASSIGNED | C15H14ClN3O4 | 2616553-35-4 | Details |
| 3-(5,6-difluoro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-Piperidinedione | C13H10F2N2O3 | 2438241-40-6 | Details |
| tert-Butyl (2-(2,6-dioxopiperidin-3-yl)-4-fluoro-1-oxoisoindolin-5-yl)carbamate | C18H20FN3O5 | 2883539-04-4 | Details |
| 1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-4-fluoro-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester | C22H27FN4O5 | 2229724-28-9 | Details |
| 2,6-Piperidinedione, 3-(4-bromo-5-fluoro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)- | C13H10BrFN2O3 | 2619512-24-0 | Details |
| 3-(6-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione | C13H12N2O4 | 1416990-09-4 | Details |
| 3-(7-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione | C13H11FN2O3 | 2287267-33-6 | Details |
| 2,6-Piperidinedione, 3-(1,3-dihydro-4-iodo-1-oxo-2H-isoindol-2-yl)- | C13H11IN2O3 | 2207541-30-6 | Details |
| 3-(6-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione | C13H13N3O3 | 191732-74-8 | Details |
| 2-Maleimido acetic acid | C6H5NO4 | 25021-08-3 | Details |
| SMCC | C16H18N2O6 | 64987-85-5 | Details |
| 4-(N-maleimidomethyl)-N-(2-propynyl)cyclohexane-1-carboxamide | C15H18N2O3 | 1036847-90-1 | Details |
| AMAS | C10H8N2O6 | 55750-61-3 | Details |
| N-Boc-(2R,3R,4S)-dolaproine | C14H25NO5 | 120205-50-7 | Details |
| BOC-DAP-NE | C23H36N2O5 | 160800-65-7 | Details |
| McMMAE | C49H78N6O10 | 863971-24-8 | Details |
| Fmoc-Val-Cit-PAB-MMAE | C73H104N10O14 | 1350456-56-2 | Details |
| Val-Cit-PAB-MMAE | C58H94N10O12 | 644981-35-1 | Details |
| MAC glucuronide linker-2 | C20H25NO11 | 229977-57-5 | Details |
| Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- | C26H29N3O6S | 2356229-14-4 | Details |
| (4S,5R)-4-Methyl-5-phenyloxazolidin-2-one | C10H11NO2 | 16251-45-9 | Details |
| (4S,5S)-4-Methyl-5-phenyl-2-oxazolidinone | C10H11NO2 | 17097-67-5 | Details |
| (4R,5R)-4-Methyl-5-phenyl-2-oxazolidinone | C10H11NO2 | 125133-96-2 | Details |
| MDL 28170 | C22H26N2O4 | 88191-84-8 | Details |
| 1-(2-Amino-5-bromo-4-methoxy-phenyl)-ethanone | C9H10BrNO2 | 1364630-89-6 | Details |
| 6-Amino-3,4-methylenedioxyacetophenone | C9H9NO3 | 28657-75-2 | Details |
| Benzbromarone | C17H12Br2O3 | ?3562-84-3 | Details |
| (4R,5S)-(+)-4-methyl-5-phenyl-2-oxazolidinone | C10H11NO2 | 77943-39-6 | Details |
| 4-(pentyloxy)benzene-1-sulfonyl chloride | C14H21ClO3S | 21095-40-9 | Details |
| Benzbromarone Impurity B | C17H11Br3O3 | 1402819-05-9 | Details |
| Benzbromarone EP Impurity A | C17H13BrO3 | 94729-09-6 | Details |
| Tenofovir alafenamide hemifumarate | C25H33N6O9P | 1392275-56-7 | Details |
| Tenofovir alafenamide | C21H29N6O5P | 379270-37-8 | Details |
| ethyl 4-(2-bromo-4-fluorophenyl)-6-methyl-2-(thiaz | C17H15BrFN3O2S | 1092952-98-1 | Details |
| Morphothiadin | C21H22BrFN4O3S | 1092970-12-1 | Details |
| 5-Pyrimidinecarboxylic acid, 4-(2-bromo-4-fluorophenyl)-1,4-dihydro-6-(4-morpholinylmethyl)-2-(2-thiazolyl)-, ethyl ester, methanesulfonate (1:1) | C22H26BrFN4O6S2 | 1646361-04-7 | Details |
| Fmoc-Val-Ala-OH | C23H26N2O5 | 150114-97-9 | Details |
| Fmoc-Val-Ala-PAB-OH | C30H33N3O5 | 1394238-91-5 | Details |
| Val-Ala-PAB-OH | C15H23N3O3 | 1343476-44-7 | Details |
| [2-(Fmoc-amino)acetamido]methyl Acetate | C20H20N2O5 | 1599440-06-8 | Details |
| Fmoc-Gly-Gly-OSU | C23H21N3O7 | 114726-49-7 | Details |
| 11-(9H-Fluoren-9-yl)-6,9-dioxo-3,10-dioxa-5,8-diazaundecanoic acid | C20H20N2O6 | 1599440-08-0 | Details |
| MC-Val-Ala-PAB-OH | C25H34N4O6 | 1870916-87-2 | Details |
| Boc-Val-Ala-PAB-PNP | C27H34N4O9 | 1884578-00-0 | Details |
| Boc-Val-Ala-PAB-OH | C20H31N3O5 | 1884577-99-4 | Details |
| MC-Val-Ala-PAB-PNP | C32H37N5O10 | 1639939-40-4 | Details |
| Fmoc-Val-Ala-PAB-PNP | C37H36N4O9 | 1394238-92-6 | Details |
| MCOSU | C14H16N2O6 | 55750-63-5 | Details |
| 2,6-Piperidinedione, 3-(6-bromo-3-benzofuranyl)- | C13H10BrNO3 | 2623101-32-4 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 1-(4-bromophenyl)dihydro- | C10H9BrN2O2 | 90772-28-4 | Details |
| Product Total： Product Page： | ||||
| 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 | ||||